These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 37316691)

  • 41. The prognostic effect of PNN in digestive tract cancers and its correlation with the tumor immune landscape in colon adenocarcinoma.
    Zhang H; Jin M; Ye M; Bei Y; Yang S; Liu K
    J Clin Lab Anal; 2022 Apr; 36(4):e24327. PubMed ID: 35257416
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification and validation of a prognostic risk-scoring model based on sphingolipid metabolism-associated cluster in colon adenocarcinoma.
    Yuan Q; Zhang W; Shang W
    Front Endocrinol (Lausanne); 2022; 13():1045167. PubMed ID: 36518255
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A bioinformatics approach to identify a disulfidptosis-related gene signature for prognostic implication in colon adenocarcinoma.
    Hu G; Yao H; Wei Z; Li L; Yu Z; Li J; Luo X; Guo Z
    Sci Rep; 2023 Jul; 13(1):12403. PubMed ID: 37524774
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of a Four-Gene Metabolic Signature to Evaluate the Prognosis of Colon Adenocarcinoma Patients.
    Zheng Y; Wu R; Wang X; Yin C
    Front Public Health; 2022; 10():860381. PubMed ID: 35462848
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic risk assessment model and drug sensitivity analysis of colon adenocarcinoma (COAD) based on immune-related lncRNA pairs.
    Hao Z; Liang P; He C; Sha S; Yang Z; Liu Y; Shi J; Zhu Z; Chang Q
    BMC Bioinformatics; 2022 Oct; 23(1):435. PubMed ID: 36258178
    [TBL] [Abstract][Full Text] [Related]  

  • 46. System analysis based on the ER stress-related genes identifies WFS1 as a novel therapy target for colon cancer.
    Yang X; Zhang C; Yan C; Ma L; Ma J; Meng X
    Aging (Albany NY); 2022 Nov; 14(22):9243-9263. PubMed ID: 36445321
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Construction of a prognostic model for colorectal adenocarcinoma based on Zn transport-related genes identified by single-cell sequencing and weighted co-expression network analysis.
    Chen H; Zhao T; Fan J; Yu Z; Ge Y; Zhu H; Dong P; Zhang F; Zhang L; Xue X; Lin X
    Front Oncol; 2023; 13():1207499. PubMed ID: 37829346
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Screening of m6A gene-related lncRNAs in colon adenocarcinoma and construction of a prognostic prediction model.
    Jin LP; Sun YW; Liu T; Tai JD
    Eur Rev Med Pharmacol Sci; 2023 Nov; 27(21):10462-10471. PubMed ID: 37975370
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sp1 contributes to overexpression of stanniocalcin 2 through regulation of promoter activity in colon adenocarcinoma.
    Li JB; Liu ZX; Zhang R; Ma SP; Lin T; Li YX; Yang SH; Zhang WC; Wang YP
    World J Gastroenterol; 2019 Jun; 25(22):2776-2787. PubMed ID: 31236000
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [High expression of ANKRD6 is an indicator for poor prognosis of colon adenocarcinoma].
    Zhao H; Liu G; Li Y; Yang N; Zhao J
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Oct; 43(10):1715-1724. PubMed ID: 37933647
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of sixteen metabolic genes as potential biomarkers for colon adenocarcinoma.
    Zhao F; Liu Y; Gu X; Zhang B; Song C; Cui B
    J BUON; 2021; 26(4):1252-1259. PubMed ID: 34564978
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Construction of disulfidptosis-related lncRNA signature for predicting the prognosis and immune escape in colon adenocarcinoma.
    Chen P; Yu J; Luo Q; Li J; Wang W
    BMC Gastroenterol; 2023 Nov; 23(1):382. PubMed ID: 37946148
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of a pyroptosis-related lncRNA risk model for predicting prognosis and immune response in colon adenocarcinoma.
    Tan Y; Lu L; Liang X; Chen Y
    World J Surg Oncol; 2022 Apr; 20(1):118. PubMed ID: 35413978
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of microsatellite instability and immune-related prognostic biomarkers in colon adenocarcinoma.
    Sun Z; Li G; Shang D; Zhang J; Ai L; Liu M
    Front Immunol; 2022; 13():988303. PubMed ID: 36275690
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased expression of GIPC2 in colon adenocarcinoma is associated with a favorable prognosis and high levels of immune cell infiltration.
    Kang M; Su Z
    Oncol Rep; 2023 Apr; 49(4):. PubMed ID: 36799193
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comprehensive analysis of m
    Liu T; Li H; Du G; Ma J; Shen J; Zhao H; Luo F; Li H
    Gene; 2022 May; 821():146250. PubMed ID: 35151825
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Construction of a prognostic model based on genes associated with mitochondrial energy metabolic pathway in colon adenocarcinoma and its clinical significance.
    Zhang X; Liang C; Zhou B; Pang L
    J Mol Recognit; 2023 Aug; 36(8):e3044. PubMed ID: 37322568
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High MICAL-L2 expression and its role in the prognosis of colon adenocarcinoma.
    Yang Y; Ye F; Xia T; Wang Q; Zhang Y; Du J
    BMC Cancer; 2022 May; 22(1):487. PubMed ID: 35501725
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Construction and validation of a prognostic model for colon adenocarcinoma based on bile acid metabolism-related genes.
    Luo Q; Zhou P; Chang S; Huang Z; Zeng X
    Sci Rep; 2023 Aug; 13(1):12728. PubMed ID: 37543674
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comprehensive Analysis Identifies PI3K/Akt Pathway Alternations as an Immune-Related Prognostic Biomarker in Colon Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitor Treatment.
    Lin A; Gu T; Hu X; Zhang J; Luo P
    J Immunol Res; 2022; 2022():8179799. PubMed ID: 35707003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.